As early as 1983, in many countries, men who have sex with men were permanently barred from donating blood because they were considered to be at high risk of HIV infection. Since the...

Epidemiological surveillance of candidates for autologous transfusion was established in France in 1993. The number of candidates increased steadily between 1993 and 1997 and then...

National epidemiological surveillance of blood donors is conducted by the French Institute for Public Health Surveillance (InVS) and the National Reference Center (CNR) for Hepatitis B...

HIV and HCV screening for recipients of labile blood products was recommended in France in 1996 by a ministerial circular. Conducted prior to transfusion and within the following four...

From 1996 to 1998, a decline in the rates of donations testing positive for the human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B surface antigen (HBsAg) was...

Objective. Among the measures likely to reduce the risk of transmission of the agent causing the new variant of Creutzfeldt-Jakob disease, excluding blood donations from donors who had...

In Europe, nonprofit plasma fractionation organizations believe that standardized epidemiological data collection and analysis is a key public health issue. These organizations are...

The presence of asymptomatic shedding of certain infectious agents poses a risk of transmission during blood transfusion. While this risk is currently well controlled for certain...

This study analyzes trends in the residual risk of transmission of HIV, HBV, and HCV through blood transfusion over eight three-year periods from 1992 to 2001 and compares, for HIV and...

Viral genomic screening (VGS) for HIV-1 and HCV was introduced in France on July 1, 2001, with the aim of enhancing transfusion safety by reducing the residual risk posed by the...